Adherence to Iron Chelation Therapy with Deferasirox Formulations among Patients with Sickle Cell Disease and β-thalassemia. uri icon

authors

  • Charity Oyedeji, MD
  • Crawford, Regina D
  • Shah, Nirmish

publication date

  • January 1, 2020